Infection with Chlamydia pneumoniae but not Helicobacter pylori is related to elevated apolipoprotein B levels

Acta Cardiol. 2005 Dec;60(6):599-604. doi: 10.2143/AC.60.6.2004930.

Abstract

Objective: Results of many studies show that apolipoprotein B (apo B) is a better marker of risk of vascular disease than other lipid markers including LDL and HDL-cholesterol and triglycerides. We investigated the association between two infectious agents: C. pneumoniae and H. pylori, known to have an atherogenic effect, and apo B, to evaluate the effects of chronic infections on apo B levels.

Methods and results: The study group consisted of 257 patients in whom diagnostic coronary angiography was performed. C. pneumoniae IgG and IgM and H. pylori IgG and IgA antibodies were measured by enzyme-linked immunosorbent assay and apo B levels were measured by the nephelometry method. Established risk factors of atherosclerosis were recorded. Of 257 patients recruited, 104 had normal vessels, 88 had 3 or more vessels obstructed and 65 had ectatic vessels without atherosclerosis. Mean apo B concentration was significantly higher in C. pneumoniae IgG and IgM positive healthy subjects compared with C. pneumoniae negatives (0.954 vs. 0.722 and 0.973 vs. 0.851, p < 0.001 and p = 0.007, respectively). Apo B levels were significantly higher in severe atherosclerotic patients (0.985 +/- 0.234 g/l) compared with control subjects (0.892 +/- 0.244 g/l) (p = 0.008), but the difference was not significant in ectatic subjects (0.946 +/- 0.272 g/l) when compared with controls (p = 0.18). Apo B levels were higher but not statistically significant in H. pylori antibody positive cases when compared with negatives.

Conclusions: Apo B levels increased with C. pneumoniae infection. This finding supports the hypothesis that lipid profiles change to atherogenic lipid profile in chronic infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Distribution
  • Antibodies, Bacterial / analysis*
  • Apolipoproteins B / analysis*
  • Biomarkers / analysis
  • Case-Control Studies
  • Chlamydophila Infections / diagnosis
  • Chlamydophila Infections / epidemiology*
  • Chlamydophila pneumoniae / immunology*
  • Coronary Angiography
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / epidemiology*
  • Coronary Artery Disease / microbiology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / epidemiology
  • Helicobacter pylori / immunology*
  • Humans
  • Immunoglobulin A / analysis
  • Immunoglobulin M / analysis
  • Incidence
  • Linear Models
  • Logistic Models
  • Male
  • Multivariate Analysis
  • Probability
  • Reference Values
  • Risk Assessment
  • Severity of Illness Index
  • Sex Distribution
  • Survival Rate
  • Turkey / epidemiology

Substances

  • Antibodies, Bacterial
  • Apolipoproteins B
  • Biomarkers
  • Immunoglobulin A
  • Immunoglobulin M